Khiron Gets Kuida® Into Another 150 Stores

  • Distribution agreement with Cafam includes initial Kuida® product orders for 49 points of sale
  • Further expansion to increase to 150 stores in first 6 months
  • Cafam operates total of 270 stores across over 60 market in Colombia
  • Accelerates Company’s multi-channel brand distribution strategy targeting $10 Billion Latin American skincare market

Khiron Life Sciences Corp, an integrated cannabis company with core operations in Latin America, has signed a distribution agreements for its Kuida® cosmeceutical brand with Cafam, a leading Colombian drugstore chain. This agreement further expands the brands points of sales In combination with the previous announced distribution arrangements this agreement further expands the brands retail and e-commerce points of sales in Colombia.

Cafam is a large Colombian conglomerate that is diversified across multiple business lines, with operations built over a 40-year history. Cafam operates 270 stores across 63 different markets in Colombia, generating annual revenue of USD $561M. The Company’s agreement with the drugstore division of Cafam, represents an initial 49 point of sale locations for Kuida®, and an agreement to expand this distribution to a total of 150 stores in the first six months of roll-out of the agreement.

Management Commentary

Mr. Alvaro Torres, CEO and Director of Khiron, comments: “We continue to see strong demand for the Kuida brand and this agreement with Cafam ensures we can reach more consumers in a convenient point-of purchase environment. As part of a multi-channel retail distribution strategy, and backed with our comprehensive product training programs this new partnership expands our reach in targeting the $10 Billion Latin American skincare market.”